MetaADEDB 2.0 @ LMMD
Dutasteride
(JWJOTENAMICLJG-QWBYCMEYSA-N)
Structure
SMILES
O=C1C=C[C@]2([C@H](N1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F)C)C
Type(s)
Approved; Investigational
ATC code(s)
G04CA52; G04CB02
Molecular Formula:
C27H30F6N2O2
Molecular Weight:
528.530
Log P:
6.9779
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
58.2
CAS Number(s):
164656-23-9
Synonym(s)
1.
Dutasteride
2.
17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one
3.
Avodart
4.
GG 745
5.
GG-745
6.
GG745
7.
GI198745
8.
745, GG
External Link(s)
MeSHD000068538
PubChem Compound6918296
BindingDB50340481
ChEBI521033
CHEMBLCHEMBL1200969
DrugBankDB01126
DrugCentral973
IUPHAR/BPS Guide to PHARMACOLOGY7457
KEGGdr:D03820
Therapeutic Target DatabaseD0A9YA
ZINC3932831
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 216
Canada Vigilance: 15
Canada Vigilance
OFFSIDES
US FAERS
2Erectile dysfunctionFAERS: 96
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
3Breast tendernessFAERS: 58
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
4Semen volume decreasedFAERS: 49OFFSIDES
SIDER
US FAERS
5DizzinessFAERS: 44
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
6Urinary RetentionFAERS: 41
Canada Vigilance: 5
Canada Vigilance
US FAERS
7DysuriaFAERS: 38
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
8Sexual DysfunctionFAERS: 36
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
9AlopeciaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
10NocturiaFAERS: 34
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
11Therapeutic response unexpectedFAERS: 34OFFSIDES
US FAERS
12FatigueFAERS: 32
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
13AstheniaFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
14Chest PainFAERS: 29
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
15PainFAERS: 29
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
16Product quality issueFAERS: 26OFFSIDES
US FAERS
17ArthralgiaFAERS: 24US FAERS
18Nipple painFAERS: 24OFFSIDES
SIDER
US FAERS
19Urinary IncontinenceFAERS: 24US FAERS
20Drug administration errorFAERS: 23OFFSIDES
US FAERS
21Drug exposure during pregnancyFAERS: 23US FAERS
22MalaiseFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Myocardial InfarctionFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
24PruritusFAERS: 22
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
25ConstipationFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
26HeadacheFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
27Pharmaceutical product complaintFAERS: 21OFFSIDES
US FAERS
28Adverse eventFAERS: 20US FAERS
29Product use issueFAERS: 20US FAERS
30Accidental exposure to productFAERS: 18US FAERS
31Accidental exposureFAERS: 18OFFSIDES
US FAERS
32NauseaFAERS: 18US FAERS
33Cerebrovascular accidentFAERS: 17US FAERS
34MyalgiaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Product substitution issueFAERS: 15
Canada Vigilance: 10
Canada Vigilance
US FAERS
36Wrong technique in product usage processFAERS: 15US FAERS
37Abdominal PainFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
38AnxietyFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
39Feeling abnormalFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Urine flow decreasedFAERS: 13OFFSIDES
US FAERS
41Blood glucose increasedFAERS: 12US FAERS
42Penile size reducedFAERS: 12OFFSIDES
US FAERS
43PneumoniaFAERS: 12US FAERS
44Benign Prostatic HyperplasiaFAERS: 11US FAERS
45jaundiceFAERS: 11US FAERS
46Back PainFAERS: 10US FAERS
47Blood testosterone decreasedFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
48Cerebral InfarctionFAERS: 10US FAERS
49DementiaFAERS: 10US FAERS
50DyspepsiaFAERS: 10US FAERS
51DysphoniaFAERS: 10OFFSIDES
US FAERS
52ErythemaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
53VomitingFAERS: 10US FAERS
54prostatitisFAERS: 10OFFSIDES
US FAERS
55AmnesiaFAERS: 9US FAERS
56Atrial FibrillationFAERS: 9US FAERS
57Blood urine presentFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
58HypotensionFAERS: 9US FAERS
59Night sweatsFAERS: 9US FAERS
60PalpitationsFAERS: 9US FAERS
61PancreatitisFAERS: 9OFFSIDES
US FAERS
62UrticariaFAERS: 9
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
63Alanine Aminotransferase IncreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Diabetes MellitusFAERS: 8US FAERS
65HypersensitivityFAERS: 8SIDER
US FAERS
66SyncopeFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Weight decreasedFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
68Abdominal discomfortFAERS: 7
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
69Angina PectorisFAERS: 7US FAERS
70BlindnessFAERS: 7US FAERS
71Burning sensationFAERS: 7US FAERS
72Chest discomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Deep Vein ThrombosisFAERS: 7US FAERS
74Exposure via body fluidFAERS: 7US FAERS
75Joint swellingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Lip swellingFAERS: 7US FAERS
77Middle insomniaFAERS: 7OFFSIDES
US FAERS
78Retrograde ejaculationFAERS: 7OFFSIDES
SIDER
US FAERS
79SwellingFAERS: 7US FAERS
80ThrombocytopeniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
81ThrombosisFAERS: 7US FAERS
82Urinary tract infectionFAERS: 7US FAERS
83nervous system disorderFAERS: 7US FAERS
84Blood testosterone increasedFAERS: 6OFFSIDES
US FAERS
85Drug dose omissionFAERS: 6US FAERS
86Dry skinFAERS: 6OFFSIDES
US FAERS
87Emotional distressFAERS: 6OFFSIDES
US FAERS
88Gastric FistulaFAERS: 6US FAERS
89Medication ErrorFAERS: 6US FAERS
90Medication residueFAERS: 6OFFSIDES
US FAERS
91NephrolithiasisFAERS: 6OFFSIDES
US FAERS
92Product preparation issueFAERS: 6US FAERS
93Prostatic painFAERS: 6US FAERS
94Pulmonary EmbolismFAERS: 6US FAERS
95Transaminases increasedFAERS: 6OFFSIDES
US FAERS
96Visual ImpairmentFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
97AcneFAERS: 5US FAERS
98AnorgasmiaFAERS: 5SIDER
US FAERS
99Aspartate Aminotransferase IncreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
100AsthmaFAERS: 5US FAERS
101BradycardiaFAERS: 5US FAERS
102CholelithiasisFAERS: 5US FAERS
103ChromaturiaFAERS: 5OFFSIDES
US FAERS
104DisabilityFAERS: 5US FAERS
105Eye painFAERS: 5OFFSIDES
US FAERS
106Gastrointestinal PainFAERS: 5US FAERS
107Incorrect route of drug administrationFAERS: 5US FAERS
108LethargyFAERS: 5US FAERS
109Medication residue presentFAERS: 5US FAERS
110Mental impairmentFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
111Musculoskeletal PainFAERS: 5US FAERS
112Musculoskeletal stiffnessFAERS: 5OFFSIDES
US FAERS
113OverdoseFAERS: 5US FAERS
114Prostatic specific antigen decreasedFAERS: 5OFFSIDES
US FAERS
115SomnolenceFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
116TremorFAERS: 5US FAERS
117Urine output increasedFAERS: 5OFFSIDES
US FAERS
118VertigoFAERS: 5US FAERS
119Blood cholesterol increasedFAERS: 4US FAERS
120Blood creatine phosphokinase increasedFAERS: 4US FAERS
121Blood testosterone free decreasedFAERS: 4US FAERS
122Coronary Artery DiseaseFAERS: 4US FAERS
123CystitisFAERS: 4US FAERS
124DeafnessFAERS: 4US FAERS
125Depressed Level of ConsciousnessFAERS: 4US FAERS
126DermatitisFAERS: 4SIDER
US FAERS
127DiscomfortFAERS: 4US FAERS
128Disease ProgressionFAERS: 4US FAERS
129FlushingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Gastric ulcerFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
131HypertransaminasaemiaFAERS: 4US FAERS
132Oropharyngeal painFAERS: 4OFFSIDES
US FAERS
133Residual urineFAERS: 4US FAERS
134RhabdomyolysisFAERS: 4US FAERS
135Skin irritationFAERS: 4US FAERS
136Stevens-Johnson SyndromeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Thermal burnFAERS: 4US FAERS
138AbasiaFAERS: 3US FAERS
139Abdominal massFAERS: 3OFFSIDES
US FAERS
140Acute myocardial infarctionFAERS: 3US FAERS
141AdenocarcinomaFAERS: 3US FAERS
142Anaphylactic shockFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
143AngerFAERS: 3US FAERS
144AscitesFAERS: 3US FAERS
145Blood alkaline phosphatase increasedFAERS: 3US FAERS
146Blood amylase increasedFAERS: 3US FAERS
147Blood potassium increasedFAERS: 3US FAERS
148Cardiac ArrestFAERS: 3US FAERS
149Circumstance or information capable of leading to medication errorFAERS: 3US FAERS
150DehydrationFAERS: 3US FAERS
151Depressed moodFAERS: 3SIDER
US FAERS
152Diabetes mellitus inadequate controlFAERS: 3OFFSIDES
US FAERS
153Dihydrotestosterone decreasedFAERS: 3US FAERS
154Drug dispensing errorFAERS: 3OFFSIDES
US FAERS
155Drug effect incompleteFAERS: 3US FAERS
156Drug prescribing errorFAERS: 3US FAERS
157EczemaFAERS: 3OFFSIDES
US FAERS
158EpididymitisFAERS: 3OFFSIDES
US FAERS
159EpilepsyFAERS: 3US FAERS
160Eye irritationFAERS: 3US FAERS
161Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
162GastritisFAERS: 3US FAERS
163GastrostomyFAERS: 3US FAERS
164High density lipoprotein increasedFAERS: 3OFFSIDES
US FAERS
165IncontinenceFAERS: 3OFFSIDES
US FAERS
166InflammationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Initial insomniaFAERS: 3OFFSIDES
US FAERS
168Intercepted product prescribing errorFAERS: 3US FAERS
169LeukopeniaFAERS: 3US FAERS
170LymphadenopathyFAERS: 3US FAERS
171Memory impairmentFAERS: 3US FAERS
172NasopharyngitisFAERS: 3US FAERS
173PancytopeniaFAERS: 3US FAERS
174Product preparation errorFAERS: 3US FAERS
175Quality of life decreasedFAERS: 3OFFSIDES
US FAERS
176Respiratory arrestFAERS: 3US FAERS
177Retinal Vein OcclusionFAERS: 3OFFSIDES
US FAERS
178Retinal vascular thrombosisFAERS: 3US FAERS
179RhinitisFAERS: 3US FAERS
180Skin noduleFAERS: 3US FAERS
181Sperm concentration decreasedFAERS: 3US FAERS
182Therapy cessationFAERS: 3US FAERS
183Throat irritationFAERS: 3US FAERS
184Unevaluable eventFAERS: 3US FAERS
185AnuriaFAERS: 2US FAERS
186Aortic AneurysmFAERS: 2US FAERS
187ApathyFAERS: 2US FAERS
188AphasiaFAERS: 2US FAERS
189Arterial therapeutic procedureFAERS: 2US FAERS
190Bilirubin conjugated increasedFAERS: 2US FAERS
191Bladder tamponadeFAERS: 2US FAERS
192Blood bilirubin unconjugated increasedFAERS: 2US FAERS
193Blood creatinine increasedFAERS: 2US FAERS
194Blood testosterone free increasedFAERS: 2OFFSIDES
US FAERS
195Breast discomfortFAERS: 2OFFSIDES
US FAERS
196CataractFAERS: 2US FAERS
197CellulitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
198CryingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
199DeliriumFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
200DisorientationFAERS: 2US FAERS
201Emotional disorderFAERS: 2US FAERS
202EpistaxisFAERS: 2US FAERS
203Free prostate-specific antigen decreasedFAERS: 2OFFSIDES
US FAERS
204FrustrationFAERS: 2US FAERS
205General physical health deteriorationFAERS: 2OFFSIDES
US FAERS
206Genital burning sensationFAERS: 2OFFSIDES
US FAERS
207GlaucomaFAERS: 2US FAERS
208GlossitisFAERS: 2US FAERS
209GoutFAERS: 2US FAERS
210HepatitisFAERS: 2US FAERS
211HerniaFAERS: 2US FAERS
212Hypertensive crisisFAERS: 2US FAERS
213HypertrichosisFAERS: 2US FAERS
214ImmobileFAERS: 2OFFSIDES
US FAERS
215Increased upper airway secretionFAERS: 2OFFSIDES
US FAERS
216InfectionFAERS: 2OFFSIDES
US FAERS
217InfluenzaFAERS: 2US FAERS
218Intervertebral disc disorderFAERS: 2US FAERS
219Joint stiffnessFAERS: 2US FAERS
220KeratoconusFAERS: 2US FAERS
221Live BirthFAERS: 2OFFSIDES
US FAERS
222Lung consolidationFAERS: 2US FAERS
223LymphomaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
224MalariaFAERS: 2OFFSIDES
US FAERS
225Male sexual dysfunctionFAERS: 2OFFSIDES
SIDER
US FAERS
226NervousnessFAERS: 2US FAERS
227No adverse eventFAERS: 2US FAERS
228NoduleFAERS: 2US FAERS
229Oral painFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
230Oropharyngeal discomfortFAERS: 2OFFSIDES
US FAERS
231Pancreatic FistulaFAERS: 2US FAERS
232Paternal exposure before pregnancyFAERS: 2US FAERS
233Peripheral arterial occlusive diseaseFAERS: 2OFFSIDES
US FAERS
234Peripheral swellingFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
235Pharmaceutical product counterfeitFAERS: 2OFFSIDES
US FAERS
236PlasmacytomaFAERS: 2OFFSIDES
US FAERS
237PresyncopeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Product counterfeitFAERS: 2US FAERS
239Product use in unapproved indicationFAERS: 2US FAERS
240Productive CoughFAERS: 2US FAERS
241Prostate indurationFAERS: 2US FAERS
242Pulmonary HypertensionFAERS: 2US FAERS
243Rash erythematousFAERS: 2US FAERS
244Rectal dischargeFAERS: 2US FAERS
245Respiratory FailureFAERS: 2US FAERS
246RestlessnessFAERS: 2US FAERS
247Retinitis PigmentosaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
248RhonchiFAERS: 2OFFSIDES
US FAERS
249SepsisFAERS: 2US FAERS
250Skeletal injuryFAERS: 2US FAERS
251Skin WrinklingFAERS: 2OFFSIDES
US FAERS
252Skin reactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
253Sperm count decreasedFAERS: 2OFFSIDES
US FAERS
254TachycardiaFAERS: 2US FAERS
255TalipesFAERS: 2OFFSIDES
US FAERS
256Therapeutic response changedFAERS: 2US FAERS
257Thyroid NeoplasmFAERS: 2US FAERS
258Transmission of drug via semenFAERS: 2US FAERS
259Trisomy 21FAERS: 2US FAERS
260Urethral StenosisFAERS: 2OFFSIDES
US FAERS
261Urethral dischargeFAERS: 2OFFSIDES
US FAERS
262Urinary bladder polypFAERS: 2OFFSIDES
US FAERS
263Urinary tract obstructionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Vulvovaginal burning sensationFAERS: 2US FAERS
265Wrong drug administeredFAERS: 2US FAERS
266Wrong technique in drug usage processFAERS: 2US FAERS
267Abdominal rigidityFAERS: 1US FAERS
268Abdominal symptomFAERS: 1OFFSIDES
US FAERS
269AbscessFAERS: 1US FAERS
270Accidental overdoseFAERS: 1US FAERS
271Activities of daily living impairedFAERS: 1US FAERS
272Acute Coronary SyndromeFAERS: 1US FAERS
273AgitationFAERS: 1US FAERS
274Aldolase increasedFAERS: 1US FAERS
275Altered state of consciousnessFAERS: 1US FAERS
276Androgenetic AlopeciaFAERS: 1US FAERS
277AneurysmFAERS: 1US FAERS
278Angle Closure GlaucomaFAERS: 1US FAERS
279Anorectal discomfortFAERS: 1OFFSIDES
US FAERS
280AnorexiaFAERS: 1US FAERS
281AnosmiaFAERS: 1US FAERS
282Antinuclear antibody increasedFAERS: 1US FAERS
283AphoniaFAERS: 1OFFSIDES
US FAERS
284Aphthous StomatitisFAERS: 1US FAERS
285ArteriosclerosisFAERS: 1US FAERS
286ArthritisFAERS: 1OFFSIDES
US FAERS
287Atrial FlutterFAERS: 1US FAERS
288AuraFAERS: 1US FAERS
289Autonomic nervous system imbalanceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
290AzoospermiaFAERS: 1US FAERS
291BedriddenFAERS: 1US FAERS
292Biopsy prostate abnormalFAERS: 1US FAERS
293Bladder neoplasm surgeryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
294Blood alcohol increasedFAERS: 1US FAERS
295Blood blisterFAERS: 1US FAERS
296Blood count abnormalFAERS: 1US FAERS
297Blood follicle stimulating hormone increasedFAERS: 1US FAERS
298Blood glucose abnormalFAERS: 1OFFSIDES
US FAERS
299Blood glucose decreasedFAERS: 1OFFSIDES
US FAERS
300Blood glucose fluctuationFAERS: 1US FAERS
301Blood iron increasedFAERS: 1OFFSIDES
US FAERS
302Blood pressure fluctuationFAERS: 1US FAERS
303Blood prolactin increasedFAERS: 1US FAERS
304Blood prolactinFAERS: 1US FAERS
305Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
306Blood triglycerides increasedFAERS: 1US FAERS
307Bone lesionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
308Bone painFAERS: 1US FAERS
309Brain natriuretic peptide increasedFAERS: 1US FAERS
310Breast CystFAERS: 1OFFSIDES
US FAERS
311Breast engorgementFAERS: 1US FAERS
312Breast hyperplasiaFAERS: 1OFFSIDES
US FAERS
313BronchospasmFAERS: 1US FAERS
314BursitisFAERS: 1US FAERS
315Cardiac FlutterFAERS: 1US FAERS
316Cardiac assistance device userFAERS: 1US FAERS
317Cataract operationFAERS: 1OFFSIDES
US FAERS
318Catheter placementFAERS: 1OFFSIDES
US FAERS
319Cerebral atrophyFAERS: 1OFFSIDES
US FAERS
320CheilitisFAERS: 1US FAERS
321ChillsFAERS: 1US FAERS
322ChloasmaFAERS: 1US FAERS
323ChokingFAERS: 1US FAERS
324CholestasisFAERS: 1US FAERS
325ColectomyFAERS: 1US FAERS
326Dark circles under eyesFAERS: 1OFFSIDES
US FAERS
327Dengue FeverFAERS: 1US FAERS
328DermatomyositisFAERS: 1US FAERS
329Diabetes InsipidusFAERS: 1US FAERS
330Diastolic dysfunctionFAERS: 1US FAERS
331Diet refusalFAERS: 1US FAERS
332DiplopiaFAERS: 1US FAERS
333DissociationFAERS: 1US FAERS
334DiverticulitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
335Drug exposure via breast milkFAERS: 1US FAERS
336Drug ineffective for unapproved indicationFAERS: 1US FAERS
337Drug screen positiveFAERS: 1US FAERS
338DysgeusiaFAERS: 1OFFSIDES
US FAERS
339DysgraphiaFAERS: 1US FAERS
340Embolic strokeFAERS: 1US FAERS
341Emotional povertyFAERS: 1US FAERS
342EnuresisFAERS: 1US FAERS
343EosinophiliaFAERS: 1US FAERS
344Erection increasedFAERS: 1US FAERS
345Erythema MultiformeFAERS: 1US FAERS
346ErythropsiaFAERS: 1US FAERS
347Expired drug administeredFAERS: 1US FAERS
348Exposure during breast feedingFAERS: 1US FAERS
349Eye inflammationFAERS: 1US FAERS
350Eyelid irritationFAERS: 1OFFSIDES
US FAERS
351Eyelid margin crustingFAERS: 1US FAERS
352False positive laboratory resultFAERS: 1US FAERS
353Feeling ColdFAERS: 1US FAERS
354Feeling of body temperature changeFAERS: 1US FAERS
355Fibroadenoma of breastFAERS: 1US FAERS
356FibromyalgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
357Floppy iris syndromeFAERS: 1US FAERS
358Food PoisoningFAERS: 1US FAERS
359Foreign body in respiratory tractFAERS: 1US FAERS
360FractureFAERS: 1US FAERS
361Gastrointestinal motility disorderFAERS: 1OFFSIDES
US FAERS
362Genital painFAERS: 1OFFSIDES
US FAERS
363Genital rashFAERS: 1OFFSIDES
US FAERS
364Gingival RecessionFAERS: 1US FAERS
365Growth retardationFAERS: 1US FAERS
366HepatotoxicityFAERS: 1US FAERS
367Hormone level abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
368HyperkeratosisFAERS: 1US FAERS
369HyperplasiaFAERS: 1US FAERS
370HypersomniaFAERS: 1US FAERS
371HypogeusiaFAERS: 1OFFSIDES
US FAERS
372HypokinesiaFAERS: 1US FAERS
373HypospadiasFAERS: 1OFFSIDES
US FAERS
374IlliteracyFAERS: 1US FAERS
375Immune thrombocytopenic purpuraFAERS: 1US FAERS
376Inappropriate schedule of product administrationFAERS: 1US FAERS
377Incorrect dose administeredFAERS: 1US FAERS
378Incorrect product storageFAERS: 1US FAERS
379Incorrect storage of drugFAERS: 1US FAERS
380InfarctionFAERS: 1US FAERS
381Intentional product use issueFAERS: 1US FAERS
382Intercepted drug administration errorFAERS: 1US FAERS
383Intestinal infarctionFAERS: 1US FAERS
384Joint Range of Motion DecreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
385Joint injuryFAERS: 1US FAERS
386LacerationFAERS: 1US FAERS
387Larynx irritationFAERS: 1US FAERS
388LeukoencephalopathyFAERS: 1US FAERS
389Ligament painFAERS: 1US FAERS
390Limb discomfortFAERS: 1OFFSIDES
US FAERS
391Limb operationFAERS: 1US FAERS
392LipomaFAERS: 1US FAERS
393Low density lipoprotein increasedFAERS: 1US FAERS
394Lower Urinary Tract SymptomsFAERS: 1US FAERS
395Lung InjuryFAERS: 1OFFSIDES
US FAERS
396Lymphocytic infiltrationFAERS: 1US FAERS
397LymphopeniaFAERS: 1US FAERS
398Macular degenerationFAERS: 1US FAERS
399Male Orgasmic DisorderFAERS: 1US FAERS
400Maternal exposure during pregnancyFAERS: 1US FAERS
401MeningiomaFAERS: 1US FAERS
402Mental FatigueFAERS: 1US FAERS
403Mental status changesFAERS: 1US FAERS
404MetaplasiaFAERS: 1US FAERS
405MetastasisFAERS: 1US FAERS
406Metastatic NeoplasmFAERS: 1OFFSIDES
US FAERS
407Micturition frequency decreasedFAERS: 1OFFSIDES
US FAERS
408MonoplegiaFAERS: 1US FAERS
409Multiple SclerosisFAERS: 1US FAERS
410Multiple allergiesFAERS: 1US FAERS
411Muscle strainFAERS: 1OFFSIDES
US FAERS
412Muscle tightnessFAERS: 1US FAERS
413Muscular DystrophyFAERS: 1US FAERS
414Musculoskeletal chest painFAERS: 1US FAERS
415Myasthenia GravisFAERS: 1US FAERS
416MyoclonusFAERS: 1US FAERS
417MyopiaFAERS: 1US FAERS
418NephritisFAERS: 1US FAERS
419Nephrotic SyndromeFAERS: 1US FAERS
420NeuralgiaFAERS: 1US FAERS
421No adverse effectFAERS: 1US FAERS
422Nonspecific reactionFAERS: 1US FAERS
423ObesityFAERS: 1US FAERS
424Ocular icterusFAERS: 1US FAERS
425OrchitisFAERS: 1OFFSIDES
US FAERS
426Orgasmic sensation decreasedFAERS: 1SIDER
US FAERS
427Osteonecrosis of JawFAERS: 1US FAERS
428OsteopeniaFAERS: 1OFFSIDES
US FAERS
429Painful ejaculationFAERS: 1US FAERS
430PallorFAERS: 1US FAERS
431Pancreatic carcinomaFAERS: 1US FAERS
432Paranasal sinus discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
433Pelvic discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
434Performance status decreasedFAERS: 1US FAERS
435Pericardial effusionFAERS: 1US FAERS
436Personality ChangeFAERS: 1US FAERS
437PetechiaeFAERS: 1US FAERS
438PharyngitisFAERS: 1US FAERS
439Pharyngolaryngeal PainFAERS: 1US FAERS
440PhotophobiaFAERS: 1US FAERS
441PneumonectomyFAERS: 1US FAERS
442PoisoningFAERS: 1US FAERS
443PolydipsiaFAERS: 1US FAERS
444Polyglandular disorderFAERS: 1US FAERS
445PolyhydramniosFAERS: 1OFFSIDES
US FAERS
446PolyuriaFAERS: 1US FAERS
447Post-Traumatic Stress DisorderFAERS: 1US FAERS
448Premature EjaculationFAERS: 1SIDER
US FAERS
449Procedural complicationFAERS: 1US FAERS
450Product complaintFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
451Product container issueFAERS: 1US FAERS
452Product package associated injuryFAERS: 1US FAERS
453Product physical issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
454Product storage errorFAERS: 1US FAERS
455Product taste abnormalFAERS: 1US FAERS
456Prostatic dysplasiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
457PsoriasisFAERS: 1US FAERS
458Psychiatric symptomFAERS: 1US FAERS
459PurpuraFAERS: 1US FAERS
460Reaction to excipientFAERS: 1US FAERS
461Rectal examination abnormalFAERS: 1US FAERS
462Rectal tenesmusFAERS: 1US FAERS
463Renal cancer metastaticFAERS: 1US FAERS
464Renal painFAERS: 1US FAERS
465Respiratory distressFAERS: 1US FAERS
466Retinal artery embolismFAERS: 1US FAERS
467Retroperitoneal fibrosisFAERS: 1US FAERS
468Rheumatoid ArthritisFAERS: 1US FAERS
469Right ventricular failureFAERS: 1US FAERS
470Rotator cuff syndromeFAERS: 1US FAERS
471SarcomaFAERS: 1US FAERS
472ScreamingFAERS: 1US FAERS
473Semen analysis abnormalFAERS: 1US FAERS
474Semen volume increasedFAERS: 1US FAERS
475Sensation of blood flowFAERS: 1US FAERS
476SinusitisFAERS: 1US FAERS
477Skin UlcerFAERS: 1US FAERS
478Skin hypertrophyFAERS: 1US FAERS
479Skin lacerationFAERS: 1US FAERS
480Skin lesionFAERS: 1OFFSIDES
US FAERS
481Skin necrosisFAERS: 1OFFSIDES
US FAERS
482Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
483SluggishnessFAERS: 1US FAERS
484SneezingFAERS: 1US FAERS
485Sperm concentration zeroFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
486SpondylolisthesisFAERS: 1US FAERS
487Stoma creationFAERS: 1US FAERS
488Subcutaneous noduleFAERS: 1US FAERS
489SunburnFAERS: 1US FAERS
490Supraventricular tachycardiaFAERS: 1US FAERS
491Temperature intoleranceFAERS: 1US FAERS
492Terminal stateFAERS: 1US FAERS
493Therapeutic response delayedFAERS: 1US FAERS
494Throat cancerFAERS: 1US FAERS
495Tongue exfoliationFAERS: 1US FAERS
496Tooth ErosionFAERS: 1US FAERS
497Toxic Epidermal NecrolysisFAERS: 1US FAERS
498Transmission of an infectious agent via a medicinal productFAERS: 1US FAERS
499Trigeminal NeuralgiaFAERS: 1US FAERS
500UlcerFAERS: 1US FAERS
501Ultrasound breast abnormalFAERS: 1US FAERS
502Urethral ObstructionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
503Urinary hesitationFAERS: 1US FAERS
504Urine calcium increasedFAERS: 1US FAERS
505Varicose vein operationFAERS: 1US FAERS
506Vasculitic rashFAERS: 1US FAERS
507Ventricular FibrillationFAERS: 1US FAERS
508Ventricular failureFAERS: 1US FAERS
509Walking aid userFAERS: 1OFFSIDES
US FAERS
510White blood cell count decreasedFAERS: 1US FAERS
511Abscess managementOFFSIDES
512Acid refluxOFFSIDES
513Alanine aminotransferase abnormalOFFSIDES
514Alpha-1 anti-trypsin increasedOFFSIDES
515AlveoloplastyOFFSIDES
516Anal FistulaOFFSIDES
517AngioedemaSIDER
518Angiogram abnormalOFFSIDES
519AnhedoniaOFFSIDES
520AnhidrosisOFFSIDES
521Ankle brachial index decreasedOFFSIDES
522Ankyloglossia acquiredOFFSIDES
523AphagiaOFFSIDES
524Aspartate aminotransferase abnormalOFFSIDES
525AsthenopiaOFFSIDES
526AtelectasisOFFSIDES
527Autologous bone marrow transplantation therapyOFFSIDES
528Band neutrophil percentage increasedOFFSIDES
529Barbiturates positiveOFFSIDES
530Basal cell carcinomaOFFSIDES
531Bladder discomfortOFFSIDES
532Bladder neck obstructionOFFSIDES
533Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
534Blood GlucoseOFFSIDES
535Blood aldosterone increasedOFFSIDES
536Blood amylaseOFFSIDES
537Blood creatinine decreasedOFFSIDES
538Blood triglycerides decreasedOFFSIDES
539Body temperature fluctuationOFFSIDES
540Bone density decreasedOFFSIDES
541Bone swellingOFFSIDES
542Breakthrough PainOFFSIDES
543BronchiolitisOFFSIDES
544BulimiaOFFSIDES
545Calcification pancreatic ductOFFSIDES
546Cardiac ablationOFFSIDES
547Cardiac stress test normalCanada Vigilance: 1Canada Vigilance
548Central nervous system lesionOFFSIDES
549Cerebral disorderCanada Vigilance: 1Canada Vigilance
550Cervical laser therapyOFFSIDES
551Cholecystitis infectiveOFFSIDES
552ClonusOFFSIDES
553Compression fractureOFFSIDES
554CryptorchidismOFFSIDES
555Culture positiveOFFSIDES
556DebridementOFFSIDES
557Decreased LibidoOFFSIDES
558DemyelinationOFFSIDES
559Dental abscessOFFSIDES
560Dental cariesOFFSIDES
561Dental prosthesis placementOFFSIDES
562Dental prosthesis userOFFSIDES
563Denture wearerOFFSIDES
564Device breakageOFFSIDES
565Disturbance in sexual arousalSIDER
566DiverticulumOFFSIDES
567DyspareuniaOFFSIDES
568Ear discomfortOFFSIDES
569Echocardiogram abnormalOFFSIDES
570Ejection Fraction DecreasedOFFSIDES
571Ejection fraction abnormalOFFSIDES
572Electrocardiogram poor R-wave progressionOFFSIDES
573EncephalomalaciaOFFSIDES
574Endodontic procedureOFFSIDES
575Enterococcal sepsisOFFSIDES
576Erosive gastritisOFFSIDES
577Erythema NodosumOFFSIDES
578Exposure to chemical pollutionOFFSIDES
579Eye InfectionOFFSIDES
580Eyelid infectionOFFSIDES
581Eyelids pruritusOFFSIDES
582Febrile NeutropeniaOFFSIDES
583Femoral arterial stenosisOFFSIDES
584Fistula dischargeOFFSIDES
585Fistula repairOFFSIDES
586Flank PainOFFSIDES
587Foreign body aspirationOFFSIDES
588FormicationOFFSIDES
589Genital discomfortOFFSIDES
590Gingival erythemaOFFSIDES
591GliosisOFFSIDES
592Head deformityOFFSIDES
593Heat ExhaustionOFFSIDES
594Hepatocellular AdenomaSIDER
595HiccoughOFFSIDES
596HidradenitisOFFSIDES
597Hormone TherapyOFFSIDES
598HydronephrosisOFFSIDES
599HyperreflexiaOFFSIDES
600HyporeflexiaOFFSIDES
601IleitisOFFSIDES
602Iliac artery stenosisOFFSIDES
603Impaired self-careOFFSIDES
604Impaired work abilityOFFSIDES
605Increased bronchial secretionOFFSIDES
606Infusion site erythemaOFFSIDES
607Inguinal massOFFSIDES
608Inhalation TherapyOFFSIDES
609Intermittent ClaudicationOFFSIDES
610Intervertebral Disc DegenerationOFFSIDES
611Invasive Ductal Breast CarcinomaCanada Vigilance: 1Canada Vigilance
612LentigoOFFSIDES
613Libido disorderOFFSIDES
SIDER
614Ligament ruptureOFFSIDES
615Lipoprotein (a) abnormalOFFSIDES
616Loose toothOFFSIDES
617Lung hyperinflationOFFSIDES
618Lysosomal Storage Diseases28551711CTD
619Malignant nipple neoplasm maleOFFSIDES
620Malignant tumour excisionOFFSIDES
621Medical device implantationOFFSIDES
622Mesenteric vascular insufficiencyOFFSIDES
623Metastases to reproductive organOFFSIDES
624Multi-organ disorderOFFSIDES
625Multiple MyelomaOFFSIDES
626Muscle FatigueOFFSIDES
627Muscle WeaknessOFFSIDES
628Muscle enzymeOFFSIDES
629Musculoskeletal discomfortOFFSIDES
630Myeloma recurrenceOFFSIDES
631OnychalgiaOFFSIDES
632Open reduction of fractureOFFSIDES
633Oral Cavity FistulaOFFSIDES
634Oral polypectomyOFFSIDES
635OsteolysisOFFSIDES
636OsteomyelitisOFFSIDES
637OsteoradionecrosisOFFSIDES
638OsteosclerosisOFFSIDES
639Oxygen supplementationOFFSIDES
640Pain of skinOFFSIDES
641Palliative CareOFFSIDES
642ParaparesisOFFSIDES
643Pelvic PainCanada Vigilance: 1Canada Vigilance
644Penile curvatureCanada Vigilance: 1Canada Vigilance
645PeriodontitisOFFSIDES
646Perirectal abscessOFFSIDES
647PhimosisOFFSIDES
648Physical disabilityOFFSIDES
649PolyneuropathyOFFSIDES
650Portal Vein ThrombosisOFFSIDES
651Post procedural infectionOFFSIDES
652Post procedural painOFFSIDES
653Posterior CapsulotomyOFFSIDES
654Posterior capsule opacificationOFFSIDES
655Primary sequestrumOFFSIDES
656Product administration errorCanada Vigilance: 1Canada Vigilance
657Prostate examination abnormalOFFSIDES
658ProstatectomyOFFSIDES
659Prostatic Hyperplasia18500220CTD
660Prostatic Neoplasms, Castration-Resistant18500220CTD
661Prostatic Neoplasms24323034
28757136
CTD
662Prostatic ObstructionOFFSIDES
663Protein total decreasedOFFSIDES
664Prothrombin level decreasedOFFSIDES
665PurulenceOFFSIDES
666Purulent dischargeOFFSIDES
667Rectal spasmOFFSIDES
668Renal cystOFFSIDES
669Renal massOFFSIDES
670Respiratory TherapyOFFSIDES
671Respiratory tract infection fungalOFFSIDES
672Retroperitoneal lymphadenopathyOFFSIDES
673RhinorrheaOFFSIDES
674Secretion dischargeOFFSIDES
675Semen viscosity abnormalOFFSIDES
676Sick Sinus SyndromeOFFSIDES
677Sinus bradycardiaOFFSIDES
678Skin neoplasm excisionOFFSIDES
679Small intestine carcinomaOFFSIDES
680Soft tissue inflammationOFFSIDES
681Spinal column stenosisOFFSIDES
682Spinal fusion surgeryOFFSIDES
683Spinal haemangiomaOFFSIDES
684SpondylolysisOFFSIDES
685Squamous cell carcinoma of skinOFFSIDES
686Stasis dermatitisOFFSIDES
687Stem cell transplantOFFSIDES
688Suture insertionOFFSIDES
689Sweat gland infectionOFFSIDES
690Swelling of eyelidCanada Vigilance: 1Canada Vigilance
691Testicular massOFFSIDES
692Testis discomfortOFFSIDES
693Therapeutic procedureOFFSIDES
694Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
695Tinea crurisOFFSIDES
696TinnitusCanada Vigilance: 1Canada Vigilance
OFFSIDES
697Tooth ExtractionOFFSIDES
698Tooth InfectionOFFSIDES
699Tooth LossOFFSIDES
700Urinary Tract PainOFFSIDES
701VasectomyOFFSIDES
702VasospasmOFFSIDES
703Venoocclusive diseaseOFFSIDES
704Venous InsufficiencyOFFSIDES
705VertebroplastyOFFSIDES
706Wound DebridementOFFSIDES
707Wound closureOFFSIDES
708intensive careOFFSIDES
709keratoacanthomaOFFSIDES
710kyphosisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.